However, recent studies have found that some cancer cells also express HLA-II in an IFN-γ-inducible manner, and the presentation of HLA-II neoantigens by cancer cells to CD4+ T cells plays an important role in activating tumor immunity [59,60]. This evidence concerns the gene CD4 and cancer.